News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
ProStrakan Group Names Peter Allen Chairman
October 30, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON (Thomson Financial) - Prostrakan PLC, the Scottish specialty biotech company, has announced that Peter Allen, a non-executive director since 2005, is to succeed Harry Stratford as Chairman after Stratford retires at the end of this year.
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
MORE ON THIS TOPIC
Layoff Tracker
Charles River, Thermo Fisher Lay Off Staff Amid Site Closures
February 6, 2026
·
51 min read
·
BioSpace Editorial Staff
GLP-1
Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill
February 6, 2026
·
1 min read
·
Tristan Manalac
Editorial
Novo Will Never Beat Lilly. Why Does It Have To?
February 5, 2026
·
3 min read
·
Annalee Armstrong
Earnings
BMS Beats Again Despite Eliquis and Cobenfy Disappointments
February 5, 2026
·
2 min read
·
Dan Samorodnitsky
